{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T03:27:47Z","timestamp":1793071667361,"version":"4.5.0"},"reference-count":34,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Chemico-Biological Interactions"],"published-print":{"date-parts":[[2021,8]]},"DOI":"10.1016\/j.cbi.2021.109561","type":"journal-article","created":{"date-parts":[[2021,6,24]],"date-time":"2021-06-24T08:12:59Z","timestamp":1624522379000},"page":"109561","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"special_numbering":"C","title":["Structural improvement of new thiazolyl-isatin derivatives produces potent and selective trypanocidal and leishmanicidal compounds"],"prefix":"10.1016","volume":"345","author":[{"given":"Luiz Alberto","family":"Barros Freitas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aline","family":"Caroline da Silva Santos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ged\u00e1lia","family":"de C\u00e1ssia Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franciely","family":"Nayara do Nascimento Albuquerque","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elis Dion\u00edsio","family":"Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos","family":"Alberto de Simone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Val\u00e9ria R\u00eago","family":"Alves Pereira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luiz Carlos","family":"Alves","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabio Andr\u00e9","family":"Brayner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana Cristina","family":"Lima Leite","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paulo Andr\u00e9 Teixeira","family":"de Moraes Gomes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cbi.2021.109561_bib1","doi-asserted-by":"crossref","first-page":"2188","DOI":"10.1016\/S0140-6736(02)09096-7","article-title":"Drug development for neglected diseases: a deficient market and a public-health policy failure","volume":"359","author":"Trouiller","year":"2002","journal-title":"Public Health\/The Lancet"},{"issue":"Suppl","key":"10.1016\/j.cbi.2021.109561_bib2","first-page":"31e40","article-title":"Epidemiology, control and surveillance of Chagas dis-ease: 100 years after its discovery","volume":"104","author":"Coura","year":"2009","journal-title":"Mem. Inst. Oswaldo Cruz"},{"key":"10.1016\/j.cbi.2021.109561_bib3","series-title":"Chagas Disease (American Trypanosomiasis)","year":"2015"},{"key":"10.1016\/j.cbi.2021.109561_bib4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/CRD.0b013e31823efde2","article-title":"Chagas heart disease: report on recent developments","volume":"20","author":"Machado","year":"2012","journal-title":"Cardiol. Rev."},{"key":"10.1016\/j.cbi.2021.109561_bib5","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0002370","volume":"7","author":"Wiggers","year":"2013","journal-title":"PLoS Neglected Trop. Dis."},{"key":"10.1016\/j.cbi.2021.109561_bib6","series-title":"Guidelines for the Diagnosis and Treatment of Chagas Disease","year":"2019"},{"issue":"1","key":"10.1016\/j.cbi.2021.109561_bib7","doi-asserted-by":"crossref","first-page":"107","DOI":"10.5123\/S1679-49742011000100012","article-title":"Treatment of visceral leishmaniasis and American cutaneous leishmaniasis in Brazil","volume":"20","author":"Pelissari","year":"2011","journal-title":"Epidemiol. Serv. Sa\u00fade, Bras\u00edlia"},{"issue":"10","key":"10.1016\/j.cbi.2021.109561_bib8","doi-asserted-by":"crossref","first-page":"2772","DOI":"10.1016\/j.bmc.2012.12.053","article-title":"Synthesis of new heterocyclic hybrids based on pyrazole and thiazolidinone scaffolds as potent inhibitors of tyrosinase","volume":"21","author":"Bandgar","year":"2013","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.cbi.2021.109561_bib9","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1007\/s00044-012-0057-3","article-title":"Design, synthesis, and biological evaluation of new 4thiazolidinone derivatives substituted with benzimidazole ring as potential chemotherapeutic agents","volume":"22","author":"Masoud","year":"2012","journal-title":"Med. Chem. Res."},{"key":"10.1016\/j.cbi.2021.109561_bib10","doi-asserted-by":"crossref","first-page":"10918","DOI":"10.1021\/jm301518v","article-title":"Structural investigation of anti-Trypanosoma cruzi 2-iminothiazolidin-4-ones allows the investigation of agents with efficacy in infected mice","volume":"55","author":"Moreira","year":"2012","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.cbi.2021.109561_bib11","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1111\/j.1747-0285.2010.01071.x","article-title":"Synthesis of 2-hydrazolyl-4-thiazolidinones based on multicomponent reactions and biological evaluation against Trypanosoma Cruzi","volume":"77","author":"Pizzo","year":"2011","journal-title":"Chem. Biol. Drug Des."},{"key":"10.1016\/j.cbi.2021.109561_bib12","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.ejmech.2014.08.012","article-title":"2-Pyridyl thiazoles as novel anti- Trypanosoma cruzi agents\u00a0: structural design, synthesis and pharmacological evaluation","volume":"86","author":"Cardoso","year":"2014","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.cbi.2021.109561_bib13","doi-asserted-by":"crossref","first-page":"7826","DOI":"10.1016\/j.bmc.2010.09.056","article-title":"Studies toward the structural optimization of novel thiazolylhydrazone-based potent antitrypanosomal agents","volume":"18","author":"Hernandes","year":"2010","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.cbi.2021.109561_bib14","doi-asserted-by":"crossref","first-page":"3749","DOI":"10.1016\/j.bmc.2006.01.034","article-title":"Synthesis, docking, and in vitro activity of thiosemicarbazones, aminoacyl-thiosemicarbazides and acyl-thiazolidones against Trypanosoma cruzi","volume":"14","author":"Leite","year":"2006","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.cbi.2021.109561_bib15","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1002\/cmdc.200700022","article-title":"Synthesis, Cruzain docking, and in vitro studies of aryl-4-oxothiazolylhydrazones against Trypanosoma cruzi","volume":"2","author":"Leite","year":"2007","journal-title":"ChemMedChem"},{"key":"10.1016\/j.cbi.2021.109561_bib16","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1016\/j.ejmech.2015.06.048","article-title":"Synthesis and structure\u2013activity relationship study of a new series of antiparasitic aryloxyl thiosemicarbazones inhibiting Trypanosoma cruzi cruzain","volume":"10","author":"Esp\u00edndola","year":"2015","journal-title":"Eur. J. Med. Chem."},{"issue":"23","key":"10.1016\/j.cbi.2021.109561_bib17","doi-asserted-by":"crossref","first-page":"7478","DOI":"10.1016\/j.bmc.2015.10.048","article-title":"Structural design, synthesis and pharmacological evaluation of 4-thiazolidinones against trypanosoma cruzi","volume":"23","author":"de Oliveira Filho","year":"2015","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.cbi.2021.109561_bib18","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1016\/j.ejmech.2015.08.013","article-title":"Aminothiazoles: hit to lead development to identify antileishmanial agents","volume":"102","author":"Bhuniya","year":"2015","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.cbi.2021.109561_bib19","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.ejmech.2014.06.022","article-title":"Synthesis and antiparasitic activity of new bis-arylimidamides: DB766 analogs modified in the terminal groups","volume":"83","author":"Liu","year":"2014","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.cbi.2021.109561_bib20","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.ejmech.2016.05.050","article-title":"New 1, 3-thiazole derivatives and their biological and ultrastructural effects on Trypanosoma cruzi","volume":"121","author":"de Moraes Gomes","year":"2016","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.cbi.2021.109561_bib21","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.ejmech.2016.01.010","article-title":"Phthalimido-thiazoles as building blocks and their effects on the growth and morphology of Trypanosoma cruzi","volume":"111","author":"de Moraes Gomes","year":"2016","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.cbi.2021.109561_bib22","series-title":"CrysAlisPro 1.171.39.35c","year":"2017"},{"key":"10.1016\/j.cbi.2021.109561_bib23","series-title":"SHELXS-97. Program for Crystal Structure Resolution","author":"Sheldrick","year":"1997"},{"key":"10.1016\/j.cbi.2021.109561_bib24","series-title":"SHELXL-97. Program for Crystal Structure Refinement","author":"Sheldrick","year":"1997"},{"key":"10.1016\/j.cbi.2021.109561_bib25","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1107\/S0021889897003117","article-title":"ORTEP-3 for windows \u2013 a version of ORTEP-III with a graphical user interface (GUI)","volume":"30","author":"Farrugia","year":"1997","journal-title":"J. Appl. Crystallogr."},{"key":"10.1016\/j.cbi.2021.109561_bib26","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1107\/S0021889899006020","article-title":"WinGX suite for small-molecule single-crystal crystallography","volume":"32","author":"Farrugia","year":"1999","journal-title":"J. Appl. Crystallogr."},{"key":"10.1016\/j.cbi.2021.109561_bib27","article-title":"New insights and innovation from a million crystal structures in the","volume":"6","author":"Cole","year":"2019","journal-title":"Cambridge Structural Database Structural Dynamics"},{"key":"10.1016\/j.cbi.2021.109561_bib28","series-title":"Dual Parasiticidal Activities of New Phthalimides: Synthesis and Biological Profile against Trypanosoma Cruzi and Plasmodium Falciparum","author":"Gomes","year":"2020"},{"issue":"4","key":"10.1016\/j.cbi.2021.109561_bib29","doi-asserted-by":"crossref","DOI":"10.1016\/j.ddtec.2004.11.007","article-title":"Lead- and drug-like compounds: the rule-of-five revolution","volume":"1","author":"Lipinski","year":"2004","journal-title":"Drug Discov. Today Technol."},{"key":"10.1016\/j.cbi.2021.109561_bib30","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0169-409X(96)00423-1","article-title":"Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings","volume":"23","author":"Lipinski","year":"1997","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"12","key":"10.1016\/j.cbi.2021.109561_bib31","doi-asserted-by":"crossref","DOI":"10.1021\/jm020017n","article-title":"Molecular properties that influence the oral bioavailability of drug candidates","volume":"45","author":"Veber","year":"2002","journal-title":"J. Med. Chem."},{"issue":"9","key":"10.1016\/j.cbi.2021.109561_bib32","doi-asserted-by":"crossref","DOI":"10.1021\/tx200211v","article-title":"Improving drug candidates by design: a focus on physicochemical properties as a means of improving compound disposition and safety","volume":"24","author":"Meanwell","year":"2011","journal-title":"Chem. Res. Toxicol."},{"key":"10.1016\/j.cbi.2021.109561_bib33","doi-asserted-by":"crossref","first-page":"2512","DOI":"10.1007\/s00044-018-2253-2","article-title":"Synthesis, antitrypanosomal activity and molecular docking studies of pyrimidine derivatives","volume":"27","author":"de Melo","year":"2018","journal-title":"Med. Chem. Res."},{"key":"10.1016\/j.cbi.2021.109561_bib34","first-page":"1","article-title":"Synthesis and anti-Trypanosoma cruzi profile of the novel 4-thiazolidinone and 1,3-thiazole derivatives","volume":"2","author":"de Siqueira","year":"2019","journal-title":"Frontiers in Drug, Chemistry and Clinical Research"}],"container-title":["Chemico-Biological Interactions"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000927972100199X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000927972100199X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,14]],"date-time":"2025-09-14T14:09:17Z","timestamp":1757858957000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S000927972100199X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8]]},"references-count":34,"alternative-id":["S000927972100199X"],"URL":"https:\/\/doi.org\/10.1016\/j.cbi.2021.109561","relation":{},"ISSN":["0009-2797"],"issn-type":[{"value":"0009-2797","type":"print"}],"subject":[],"published":{"date-parts":[[2021,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Structural improvement of new thiazolyl-isatin derivatives produces potent and selective trypanocidal and leishmanicidal compounds","name":"articletitle","label":"Article Title"},{"value":"Chemico-Biological Interactions","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cbi.2021.109561","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"109561"}}